Skip to main content
FinSpry Logo
FinSpry
CCCC logo
CCCC
(NASDAQ)
C4 Therapeutics, Inc.
$2.82-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

C4 Therapeutics (CCCC) Stock Price & Financial Analysis

C4 Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.60 - $2.84
52-Week High$3.82
52-Week Low$1.09
Open$2.63
Volume2.13M
Average Volume (3M)2.13M
Market Cap233.76M
Shares Outstanding82.89M
Price to Sales (P/S)6.23
Price to Book (P/B)0.87
EV/EBITDA-2.10
Revenue (TTM)35.95M
Net Income (TTM)-104.99M
Free Cash Flow (TTM)-99.30M
EPS (TTM)$-1.27
Profit Margin-292.08%
Operating Margin-290.68%
Return on Equity (ROE)-40.92%
Debt to Equity0.23
50-Day MA$2.41
200-Day MA$2.33
52-Week Change88.15%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About C4 Therapeutics

What is the current stock price for CCCC?

As of the latest trading session, CCCC stock trades at $2.82. The 52-week range is $1.09–$3.82, with a day range of $2.60–$2.84.

What is the P/E ratio for CCCC?

The P/E ratio (Price-to-Earnings) for CCCC is shown in the Key Statistics section. This valuation metric helps compare C4 Therapeutics, Inc. to industry peers.

Does CCCC pay dividends?

C4 Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CCCC?

Based on 2 analysts, the consensus for CCCC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CCCC?

C4 Therapeutics's market capitalization is $233.8M, classifying it as a micro-cap company. C4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.